The
molecular detection of multiple respiratory viruses
provides
evidence for the rational use of drugs and effective health management.
Herein, we developed and tested the clinical performance of an electrohydrodynamic-driven
nanobox-on-mirror platform (E-NoM) for the parallel, accurate, and
sensitive detection of four respiratory viral antigens. The E-NoM
platform uses gold–silver alloy nanoboxes as the core material
with the deposition of a silver layer as a shell on the core surfaces
to amplify and enable a reproducible Raman signal readout that facilitates
accurate detection. Additionally, the E-NoM platform employs gold
microelectrode arrays as the mirror with electrohydrodynamics to manipulate
the fluid flow and enhance molecular interactions for an improved
biosensing response. The presence of viral antigens binds the nanobox-based
core–shell nanostructure on the gold microelectrode and creates
the nanocavity with extremely strong “hot spots” to
benefit sensitive analysis. Significantly, in a large clinical cohort
with 227 patients, the designed E-NoM platform demonstrates the capability
of screening respiratory infection with achieved clinical specificity,
sensitivity, and accuracy of 100.0, 96.48, and 96.91%, respectively.
It is anticipated that the E-NoM platform can find a position in clinical
usage for respiratory disease diagnosis.